Transfusion reaction

Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005 Apr;33(4):721-6. Abstract

Kuriyan M, Carson JL. Blood transfusion risks in the intensive care unit. Crit Care Clin. 2004 Apr;20(2):237-53. Abstract

1. AABB. Circular of information for the use of human blood and blood components. Oct 2017 [internet publication].Full text

2. Linden JV, Wagner K, Voytovich AE, et al. Transfusion errors in New York state: an analysis of 10 years' experience. Transfusion. 2000 Oct;40(10):1207-13. Abstract

3. Spiess BD. Risks of transfusion: outcome focus. Transfusion. 2004 Dec;44(12 Suppl):4S-14S. Abstract

4. Karim F, Moiz B, Shamsuddin N, et al. Root cause analysis of non-infectious transfusion complications and the lessons learnt. Transfus Apher Sci. 2014 Feb;50(1):111-7. Abstract

5. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion. 1990 Sep;30(7):583-90. Abstract

6. Serious Hazards of Transfusion. SHOT report 2008. Jun 2009 [internet publication].Full text

7. Yazer MH, Podlosky L, Clarke G, et al. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion. 2004 Jan;44(1):10-5. Abstract

8. Paglino JC, Pomper GJ, Fisch GS, et al. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion. 2004 Jan;44(1):16-24. Abstract

9. King KE, Shirey RS, Thoman SK, et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion. 2004 Jan;44(1):25-9. Abstract

10. Tobian AA, King KE, Ness PM. Transfusion premedications: a growing practice not based on evidence. Transfusion. 2007 Jun;47(6):1089-96. Abstract

11. Domen RE, Hoeltge GA. Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med. 2003 Mar;127(3):316-20.Full text  Abstract

12. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev. 2006 Oct;20(4):273-82. Abstract

13. Vamvakas EC, Pineda AA, Reisner R, et al. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion. 1995 Jan;35(1):26-32. Abstract

14. Mazzei CA, Popovsky MA, Kopko PM. Noninfectious complications of blood transfusion. In: Roback JD, Combs MR, Grossman BJ, et al., eds. Technical Manual, 16th Ed. Bethesda, MD: American Association of Blood Banks; 2008:715-49.

15. Finlay HE, Cassorla L, Feiner J, et al. Designing and testing a computer-based screening system for transfusion-related acute lung injury. Am J Clin Pathol. 2005 Oct;124(4):601-9. Abstract

16. Rana R, Fernandez-Perez ER, Khan SA, et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion. 2006 Sep;46(9):1478-83. Abstract

17. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005 Mar 15;105(6):2266-73. Abstract

18. Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest. 2004 Jul;126(1):249-58. Abstract

19. Oltean S, Epure A, Lindström K, et al. Detection of anti-IgA antibodies using the particle gel immunoassay: a rapid test for increased patient safety. Blood Transfus. 2014 Jan 16;12(3):334-9.Full text  Abstract

20. Heddle NM. Pathophysiology of febrile nonhemolytic transfusion reactions. Curr Opin Hematol. 1999 Nov;6(6):420-6. Abstract

21. Middelburg RA, van Stein D, Briët E, et al. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion. 2008 Oct;48(10):2167-76. Abstract

22. Semple JW, Rebetz J, Kapur R. Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood. 2019 Apr 25;133(17):1840-53.Full text  Abstract

23. Dwyre DM, Holland PV. Transfusion-associated graft-versus-host disease. Vox Sang. 2008 Aug;95(2):85-93. Abstract

24. Harewood J, Master SR. Hemolytic Transfusion Reaction. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019.Full text  Abstract

25. Yomtovian RA, Palavecino EL, Dykstra AH, et al. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Transfusion. 2006 May;46(5):719-30. Abstract

26. Leiby DA, Kerr KL, Campos JM, et al. A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites. Transfusion. 1997 Mar;37(3):259-63. Abstract

27. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005 Apr;33(4):721-6. Abstract

28. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis--an overview for clinicians. Crit Care. 2005 Apr;9(2):158-69.Full text  Abstract

29. Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis--a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015 Nov;115(5):341-84.Full text  Abstract

30. Mueller-Eckhardt C, Kiefel V. High-dose IgG for post-transfusion purpura--revisited. Blut. 1988 Oct;57(4):163-7. Abstract

31. Anderson D, Ali K, Blanchette V, et al. Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus Med Rev. 2007 Apr;21(2 suppl 1):S9-56. Abstract

32. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000 Aug;30(8):1144-50. Abstract

33. Kuriyan M, Carson JL. Blood transfusion risks in the intensive care unit. Crit Care Clin. 2004 Apr;20(2):237-53. Abstract

34. Perrota PL, Snyder EL. Non-infectious complications of transfusion therapy. Blood Rev. 2001 Jun;15(6):69-83. Abstract

35. Geiger TL, Howard SC. Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev. 2007 Jan;21(1):1-12.Full text  Abstract

36. Blajchman MA. The clinical benefits of the leukoreduction of blood products. J Trauma. 2006 Jun;60(6 Suppl):S83-90. Abstract

37. Martí-Carvajal AJ, Solà I, González LE, et al. Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions. Cochrane Database Syst Rev. 2010 Jun 16;6:CD007539. Abstract

38. Australian & New Zealand Society of Blood Transfusion. Guidelines for prevention of transfusion-associated graft-versus-host disease (TA-GVHD). Sydney, Australia: Australian & New Zealand Society of Blood Transfusion Ltd; 2011.Full text

39. Middelburg RA, van Stein D, Zupanska B, et al. Female donors and transfusion-related acute lung injury. Transfusion. 2010 Nov;50(11):2447-54. Abstract

40. Schmickl CN, Mastrobuoni S, Filippidis FT, et al. Male-predominant plasma transfusion strategy for preventing transfusion-related acute lung injury: a systematic review. Crit Care Med. 2015 Jan;43(1):205-25. Abstract

41. Müller MC, van Stein D, Binnekade JM, et al. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis. Transfusion. 2015 Jan;55(1):164-75.Full text  Abstract

42. Chassé M, McIntyre L, English SW, et al. Effect of blood donor characteristics on transfusion outcomes: a systematic review and meta-analysis. Transfus Med Rev. 2016 Feb 9;30(2):69-80.Full text  Abstract